Emerging evidence shows that severe coronavirus disease 2019 (COVID‐19) can be
complicated with coagulopathy, namely disseminated intravascular coagulation, which has …

A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …

Background A significant proportion of patients with coronavirus disease 19 (COVID-19)
suffer from excessive coagulation activation and coagulopathy which is associated with an …

COVID-19 is associated with a high incidence of thrombotic complications, which can be
explained by the complex and unique interplay between coronaviruses and endothelial …

Abstract Corona virus 2 (SARS-CoV2/Severe Acute Respiratory Syndrome Corona Virus 2)
infection has emerged as a global health crisis. Incidence of thromboembolic disease is …

At this time last year, it was farfetched if not impossible to think of the immense changes and
challenges to people and the society in 2020. Social distancing has become the norm in …

Abstract Purpose of Review We aim to provide a comprehensive analysis of
hypercoagulability in individuals affected by COVID-19. Our goal is to describe the …

Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a global public health concern and is …

Background. A prothrombotic state, attributable to excessive inflammation, cytokine storm,
hypoxia, and immobilization, is a feature of SARS-CoV-2 infection. Up to 30% of patients …